http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-2646302-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8f48f41f1eecc9119c9a87a241502343
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C22B34-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C22B9-106
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C22B34-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C22B9-10
filingDate 1976-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c67d1f09447a3d3f5fe369f39eafdd30
publicationDate 1977-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber DE-2646302-A1
titleOfInvention METHOD OF REDUCING ZIRCONIUM
abstract A molten-salt phase contg. the Zr cpd. to be reduced is prepd. and contacted with a liq. metallic phase contg. a reducing metal more electropositive than Zr and a metal solvent less electropositive than Zr. The Zr cpd. is reduced by the reducing metal which passes from the metallic phase to the molten salt phase, and the Zr passes in the opposite direction. The solvent is Zn, Cd, Pb, Bi, Cu or Sn (pref. Zn). The reducing metal is Mg, Na, Cd, or pref. Al. The Zr cpd. is pref. Na2ZrF6. The amt. of Al present is sufficient for the reduction of 85-98% of the Na2ZrF6 to Zr. The cpd. Na2ZrF6 is reduced forming (NaF)1.5.AlF3 which is almost pure and which is then separated from the molten phase. The molten salt phase contains salts other than Zr cpds. The cations of these salts are more electropositive than those of Zr. Part of these cations are selected from alkali metals, alkaline earths, rare earths and Al. The anions of these salts are halogen; Cl or F.
priorityDate 1976-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5462224
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452315161
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16693908
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID61775
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452894733
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24551
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559168
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23995
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22182891
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23994
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419520552
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449029786
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559552
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID82216
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559553
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23978
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491804
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5359367
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID418354341
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5360545
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559021
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458437694
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449140574
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419549759
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2124
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23973
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID28127
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419577487
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419579535
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24817
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419520549
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5359268

Total number of triples: 45.